Literature DB >> 27656538

Evaluation of Placental Extracts as an Adjuvant Therapy to Phenol in Treatment of Idiopathic Guttate Hypomelanolsis.

Kalpana Gupta1, Swati Tripathi2, Manjinder Kaur3.   

Abstract

INTRODUCTION: Idiopathic Guttate Hypomelanolsis (IGH) macules are hypo pigmented lesions occurring due to decreased functioning of melanocytes due to photosensitivity or persistent irritation of skin in middle aged and elderly. AIM: To find out the efficacy of placental extracts when used as an adjunct with 88% phenol for the treatment of IGH macules.
MATERIALS AND METHODS: A total of 40 patients were randomly divided into two groups (n=20 in each group), viz group P, (the control group, treated with only 88% phenol) and Group PP (study group, treated with Placental extracts along with 88% phenol). Spot peeling was done with 88% phenol in both the groups while group PP was advised to use placental extract at night for 3 months. Patients of both groups were assessed both subjectively and objectively after every session and at the end of 3 months of initiation of therapy. The statistical analysis was done using Chi-square test, Z-test and a p-value<0.05 was considered significant.
RESULTS: Both the groups showed significant re-pigmentation of lesions i.e., 76.8% in group P and 79.1% in group PP; whereas, what group PP had shown was non- significantly (p=0.8203) better as compared to group P.
CONCLUSION: The clinical and patient acceptability of phenol along with the placental extracts as an adjuvant was better with similar results. Hence, the use of placental extract is recommended along with phenol in IGH lesions.

Entities:  

Keywords:  Carbolic acid; Hypopigmented lesion; Placentrex; Therapeutic wounding

Year:  2016        PMID: 27656538      PMCID: PMC5028554          DOI: 10.7860/JCDR/2016/21095.8325

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

1.  Treatment of idiopathic guttate hypomelanosis by localized superficial dermabrasion.

Authors:  D M Hexsel
Journal:  Dermatol Surg       Date:  1999-11       Impact factor: 3.398

2.  3-5 second cryotherapy is effective in idiopathic guttate hypomelanosis.

Authors:  Sujith Prasad W Kumarasinghe
Journal:  J Dermatol       Date:  2004-05       Impact factor: 4.005

3.  Topical placental extract: does it increase the efficacy of narrowband UVB therapy in vitiligo?

Authors:  Imran Majid
Journal:  Indian J Dermatol Venereol Leprol       Date:  2010 May-Jun       Impact factor: 2.545

Review 4.  Surgical therapy of vitiligo: current status.

Authors:  Satish S Savant
Journal:  Indian J Dermatol Venereol Leprol       Date:  2005 Sep-Oct       Impact factor: 2.545

5.  [Progressive symmetrical leukopathia of the extremities].

Authors:  O G COSTA
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1951 Jul-Aug

6.  Dermabrasion may repigment vitiligo through stimulation of melanocyte precursors and elimination of hyperkeratosis.

Authors:  Sherif Shoukry Awad
Journal:  J Cosmet Dermatol       Date:  2012-12       Impact factor: 2.696

7.  Chemical peeling with phenol : For the treatment of stable vitiligo and alopecia areata.

Authors:  S S Savant; S Shenoy
Journal:  Indian J Dermatol Venereol Leprol       Date:  1999 Mar-Apr       Impact factor: 2.545

8.  Comprehensive understanding of idiopathic guttate hypomelanosis: clinical and histopathological correlation.

Authors:  Sue Kyung Kim; En Hyung Kim; Hee Young Kang; Eun-So Lee; Seonghyang Sohn; You Chan Kim
Journal:  Int J Dermatol       Date:  2010-02       Impact factor: 2.736

9.  Topical tacrolimus significantly promotes repigmentation in idiopathic guttate hypomelanosis: a double-blind, randomized, placebo-controlled study.

Authors:  P Rerknimitr; W Disphanurat; M Achariyakul
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-02-10       Impact factor: 6.166

10.  Therapeutic wounding - 88% phenol in idiopathic guttate hypomelanosis.

Authors:  Shilpashree P Ravikiran; S Sacchidanand; B Leelavathy
Journal:  Indian Dermatol Online J       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.